Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

By Ye Yao   Vattai Aurelia   Zhang Xi   Zhu Junyan   Thaler Christian J.   Mahner Sven   Jeschke Udo   von Schönfeldt Viktoria  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-07 ,pp. : 1651-1651

MDPI

Access to resources Recommend Favorite

Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women

By Kim Jung Oh   Han Soo Hong   Lee Yeon Ho   Ahn Tae Keun   Lim Jae Joon   Chung Young Sun   Shin Dong Eun   Lee Woo Sik   Han In Bo   Kim Nam Keun  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2062-2062

MDPI

Access to resources Recommend Favorite

The Novel HDAC8 Inhibitor WK2-16 Attenuates Lipopolysaccharide-Activated Matrix Metalloproteinase-9 Expression in Human Monocytic Cells and Improves Hypercytokinemia In Vivo

By Jan Jing-Shiun   Chou Yung-Chen   Cheng Yu-Wen   Chen Chih-Kuang   Huang Wei-Jan   Hsiao George  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1394-1394

MDPI

Access to resources Recommend Favorite

Treatment with the Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone Suppresses SEB-Induced Lung Inflammation

By McKallip Robert J.   Hagele Harriet F.   Uchakina Olga N.  

Toxins, Vol. 5, Iss. 10, 2013-10 ,pp. : 1814-1826

MDPI

Access to resources Recommend Favorite

In Silico Screening Identifies a Novel Potential PARP1 Inhibitor Targeting Synthetic Lethality in Cancer Treatment

By Li Jian   Zhou Nan   Cai Peiling   Bao Jinku  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 258-258

MDPI

Access to resources Recommend Favorite